AI identifies potential Parkinson's treatments, accelerating drug discovery

Summary: Researchers at the University of Cambridge utilized AI to identify five potential Parkinson's disease treatments by screening millions of compounds. This AI-driven approach accelerated the process tenfold, reducing costs significantly. With over six million global Parkinson's patients, this advancement is crucial as the condition is projected to triple by 2040. The study, published in Nature Chemical Biology, highlights a major leap in drug discovery efficiency.

Full article